These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22192821)
1. Inhibition of Rho kinases increases directional motility of microvascular endothelial cells. Breyer J; Samarin J; Rehm M; Lautscham L; Fabry B; Goppelt-Struebe M Biochem Pharmacol; 2012 Mar; 83(5):616-26. PubMed ID: 22192821 [TBL] [Abstract][Full Text] [Related]
2. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway. Li Y; Wu Y; Wang Z; Zhang XH; Wu WK Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of endothelial progenitor cell numbers and migration by H1152, a Rho kinase specific inhibitor. O E; Lee SW; Lee HS; Lim HS; Ahn HY; Shin JC; Kim Y; Joe YA Biosci Biotechnol Biochem; 2012; 76(1):172-5. PubMed ID: 22232255 [TBL] [Abstract][Full Text] [Related]
4. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway. Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296 [TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions. Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233 [TBL] [Abstract][Full Text] [Related]
8. Endothelial repair in stented arteries is accelerated by inhibition of Rho-associated protein kinase. Hsiao ST; Spencer T; Boldock L; Prosseda SD; Xanthis I; Tovar-Lopez FJ; Van Beusekom HM; Khamis RY; Foin N; Bowden N; Hussain A; Rothman A; Ridger V; Halliday I; Perrault C; Gunn J; Evans PC Cardiovasc Res; 2016 Dec; 112(3):689-701. PubMed ID: 27671802 [TBL] [Abstract][Full Text] [Related]
9. ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. Takeda Y; Matoba K; Kawanami D; Nagai Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884801 [TBL] [Abstract][Full Text] [Related]
10. Matrix-independent stimulation of human tubular epithelial cell migration by Rho kinase inhibitors. Kroening S; Stix J; Keller C; Streiff C; Goppelt-Struebe M J Cell Physiol; 2010 Jun; 223(3):703-12. PubMed ID: 20175114 [TBL] [Abstract][Full Text] [Related]
11. The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro. Tura A; Grisanti S; Petermeier K; Henke-Fahle S Invest Ophthalmol Vis Sci; 2007 May; 48(5):2152-61. PubMed ID: 17460274 [TBL] [Abstract][Full Text] [Related]
12. Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models. Meekins LC; Rosado-Adames N; Maddala R; Zhao JJ; Rao PV; Afshari NA Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6731-6738. PubMed ID: 27951595 [TBL] [Abstract][Full Text] [Related]
13. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase. Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912 [TBL] [Abstract][Full Text] [Related]
14. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts. Burger D; Montezano AC; Nishigaki N; He Y; Carter A; Touyz RM Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1898-907. PubMed ID: 21597004 [TBL] [Abstract][Full Text] [Related]
15. Rho-kinase and myosin II activities are required for cell type and environment specific migration. Nakayama M; Amano M; Katsumi A; Kaneko T; Kawabata S; Takefuji M; Kaibuchi K Genes Cells; 2005 Feb; 10(2):107-17. PubMed ID: 15676022 [TBL] [Abstract][Full Text] [Related]
16. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures. O E; Ahn HY; Kim HK; You JC; Shin JC; Joe YA Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077 [TBL] [Abstract][Full Text] [Related]
17. Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia. Yagita Y; Kitagawa K; Sasaki T; Terasaki Y; Todo K; Omura-Matsuoka E; Kaibuchi K; Hori M J Neurosci Res; 2007 Aug; 85(11):2460-9. PubMed ID: 17526023 [TBL] [Abstract][Full Text] [Related]
18. Activation of Rho kinase isoforms in lung endothelial cells during inflammation. Mong PY; Wang Q J Immunol; 2009 Feb; 182(4):2385-94. PubMed ID: 19201893 [TBL] [Abstract][Full Text] [Related]